Pharmacovigilance of thalidomide in the Brazilian Health System and patient safety
Braz. J. Pharm. Sci. (Online); 56 (), 2020
In Brazil, thalidomide is manufactured by a public laboratory, distributed by the Unified Health System (SUS), and regulated by the National Health Surveillance Agency (Anvisa). Despite the concerns regarding the adverse effects of thalidomide, few drug utilization studies have been conducted to describe...
Agencia Nacional de Vigilancia Sanitaria, Farmacovigilancia, Pacientes Ambulatorios/clasificación, Seguridad del Paciente/normas, Sistema Único de Salud/clasificación, Talidomida/análisis, Vigilancia Sanitaria/organización & administración, Salud/normas, Informe de Investigación, Preparaciones Farmacéuticas/administración & dosificación